Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment

Kimihito Maeda, Yuichiro Ohara, Masato Hashimoto, Hiroshi OhguroDepartment of Ophthalmology, Sapporo Medical University, School of Medicine, Sapporo, JapanPurpose: To investigate whether serum levels of soluble Fas (sFas) and interleukin-6 (IL-6) could function as an index of the efficacy of steroid...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kimihito Maeda, Yuichiro Ohara, Masato Hashimoto, Hiroshi Ohguro
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/a7d89e6d2f924dec8dfd78f1928c5f5d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a7d89e6d2f924dec8dfd78f1928c5f5d
record_format dspace
spelling oai:doaj.org-article:a7d89e6d2f924dec8dfd78f1928c5f5d2021-12-02T09:47:18ZAnalysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment1177-54671177-5483https://doaj.org/article/a7d89e6d2f924dec8dfd78f1928c5f5d2008-10-01T00:00:00Zhttp://www.dovepress.com/analysis-of-sfas-il-6-levels-in-thyroid-associated-ophthalmopathy-pre--a2368https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Kimihito Maeda, Yuichiro Ohara, Masato Hashimoto, Hiroshi OhguroDepartment of Ophthalmology, Sapporo Medical University, School of Medicine, Sapporo, JapanPurpose: To investigate whether serum levels of soluble Fas (sFas) and interleukin-6 (IL-6) could function as an index of the efficacy of steroid pulse treatment, we examined the serum level of these proteins before and after steroid pulse treatment in thyroid-associated ophthalmopathy patients.Methods: We gathered the blood of thyroid-associated ophthalmopathy patients before or after steroid pulse treatment, obtained serum with a centrifuge, and measured the serum levels of sFas and IL-6 by enzyme-linked immunosorbent assay (ELISA).Results: There was no difference in serum IL-6 value between pre- and poststeroid pulse treatment. Serum sFas value was significantly decreased in both pre- and poststeroid pulse treatment. Furthermore, there was a recognizable improvement in the degree of the extraocular muscle thickening after treatment in cases in whom the serum sFas value was lower than 3 ng/ml prior to the beginning of the therapy. In patients who had a serum sFas value of more than 3 ng/ml, there was no improvement in the degree of thickening of the extraocular muscle.Conclusions: Serum level of sFas is an accurate index of the outcome of steroid pulse treatment in thyroid-associated ophthalmopathy and may become a useful index to gauge the status of convalescence.Keywords: sFas, IL-6, ELISA, thyroid associated ophthalmopathy, steroid pulse treatment Kimihito MaedaYuichiro OharaMasato HashimotoHiroshi OhguroDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2008, Iss Issue 3, Pp 609-612 (2008)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Kimihito Maeda
Yuichiro Ohara
Masato Hashimoto
Hiroshi Ohguro
Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment
description Kimihito Maeda, Yuichiro Ohara, Masato Hashimoto, Hiroshi OhguroDepartment of Ophthalmology, Sapporo Medical University, School of Medicine, Sapporo, JapanPurpose: To investigate whether serum levels of soluble Fas (sFas) and interleukin-6 (IL-6) could function as an index of the efficacy of steroid pulse treatment, we examined the serum level of these proteins before and after steroid pulse treatment in thyroid-associated ophthalmopathy patients.Methods: We gathered the blood of thyroid-associated ophthalmopathy patients before or after steroid pulse treatment, obtained serum with a centrifuge, and measured the serum levels of sFas and IL-6 by enzyme-linked immunosorbent assay (ELISA).Results: There was no difference in serum IL-6 value between pre- and poststeroid pulse treatment. Serum sFas value was significantly decreased in both pre- and poststeroid pulse treatment. Furthermore, there was a recognizable improvement in the degree of the extraocular muscle thickening after treatment in cases in whom the serum sFas value was lower than 3 ng/ml prior to the beginning of the therapy. In patients who had a serum sFas value of more than 3 ng/ml, there was no improvement in the degree of thickening of the extraocular muscle.Conclusions: Serum level of sFas is an accurate index of the outcome of steroid pulse treatment in thyroid-associated ophthalmopathy and may become a useful index to gauge the status of convalescence.Keywords: sFas, IL-6, ELISA, thyroid associated ophthalmopathy, steroid pulse treatment
format article
author Kimihito Maeda
Yuichiro Ohara
Masato Hashimoto
Hiroshi Ohguro
author_facet Kimihito Maeda
Yuichiro Ohara
Masato Hashimoto
Hiroshi Ohguro
author_sort Kimihito Maeda
title Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment
title_short Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment
title_full Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment
title_fullStr Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment
title_full_unstemmed Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment
title_sort analysis of sfas il-6 levels in thyroid-associated ophthalmopathy: pre- or poststeroid pulse treatment
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/a7d89e6d2f924dec8dfd78f1928c5f5d
work_keys_str_mv AT kimihitomaeda analysisofsfasil6levelsinthyroidassociatedophthalmopathypreorpoststeroidpulsetreatment
AT yuichiroohara analysisofsfasil6levelsinthyroidassociatedophthalmopathypreorpoststeroidpulsetreatment
AT masatohashimoto analysisofsfasil6levelsinthyroidassociatedophthalmopathypreorpoststeroidpulsetreatment
AT hiroshiohguro analysisofsfasil6levelsinthyroidassociatedophthalmopathypreorpoststeroidpulsetreatment
_version_ 1718398024335491072